Juvenile Diabetes

Diabetes mellitus type 1 (Type 1 diabetes, T1D, T1DM, IDDM, juvenile diabetes) is a form of diabetes mellitus. Type 1 diabetes is an autoimmune disease that results in destruction of insulin-producing beta cells of the pancreas. Lack of insulin causes an increase of fasting blood glucose (around 70-120 mg/dL in nondiabetic people) that begins to appear in the urine above the renal threshold (about 190-200 mg/dl in most people), thus connecting to the symptom by which the disease was identified in antiquity, sweet urine.
What is Type 1 Diabetes?

Type 1 diabetes mellitus describes a condition where the body cannot produce insulin which leads to a very high level of blood sugar and associated complications. The condition, which usually develops in childhood or adolescence, affects millions of people worldwide.

Read More

Overview

Feature Articles

Latest Juvenile Diabetes News and Research

Implantable mechanotherapeutic drug delivery platform helps overcome host immune response

Implantable mechanotherapeutic drug delivery platform helps overcome host immune response

Researchers may be one step closer to preventing Type 1 diabetes

Researchers may be one step closer to preventing Type 1 diabetes

Blood levels of ceramides could help predict type 2 diabetes remission after gastric bypass surgery

Blood levels of ceramides could help predict type 2 diabetes remission after gastric bypass surgery

Novel approach allows islet transplants to survive and control diabetes

Novel approach allows islet transplants to survive and control diabetes

Novel Type 1 diabetes treatment involves pancreatic islet transplant without the need for immunosuppression

Novel Type 1 diabetes treatment involves pancreatic islet transplant without the need for immunosuppression

Study shows how co-transplanting islet cells with SA-FasL-microgels reverses diabetic symptoms

Study shows how co-transplanting islet cells with SA-FasL-microgels reverses diabetic symptoms

Researchers design RNA molecules for delivering therapies directly to beta cells

Researchers design RNA molecules for delivering therapies directly to beta cells

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Epigenetic changes could be a biomarker for early detection of type 1 diabetes

Using oral blood pressure drug to treat Type 1 diabetes shows benefits for at least two years

Using oral blood pressure drug to treat Type 1 diabetes shows benefits for at least two years

Researchers identify a cellular pathway that causes pancreatic beta cells to die in type 1 diabetes

Researchers identify a cellular pathway that causes pancreatic beta cells to die in type 1 diabetes

Newly discovered hormone may play a key role in the development of type 1 and type 2 diabetes

Newly discovered hormone may play a key role in the development of type 1 and type 2 diabetes

New hormone may play a key role in the development of type 1 and type 2 diabetes

New hormone may play a key role in the development of type 1 and type 2 diabetes

Scientists identify new gene that contributes to type 1 diabetes progression

Scientists identify new gene that contributes to type 1 diabetes progression

Therapeutics that target ceramides may help treat cardiometabolic disease

Therapeutics that target ceramides may help treat cardiometabolic disease

New convection-enhanced MEDs could offer faster, more effective treatment for T1D patients

New convection-enhanced MEDs could offer faster, more effective treatment for T1D patients

Small protein prevents immune system from destroying pancreatic cells in type 1 diabetes-prone mice

Small protein prevents immune system from destroying pancreatic cells in type 1 diabetes-prone mice

Largest genetic study identifies new drug targets to treat type 1 diabetes

Largest genetic study identifies new drug targets to treat type 1 diabetes

Novel method for glucagon delivery to help individuals living with Type 1 diabetes

Novel method for glucagon delivery to help individuals living with Type 1 diabetes

Scientists outline new target for treating type 2 diabetes

Scientists outline new target for treating type 2 diabetes

New biomaterial for pancreatic islet transplants does not trigger the body's immune response

New biomaterial for pancreatic islet transplants does not trigger the body's immune response